Nippon Tungsten Co., Ltd. (TYO:6998)

Verve Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	6,305	5,878	6,224	6,291	5,280	4,363
Market Cap Growth	-5.56%	-5.56%	-1.05%	19.15%	21.02%	8.26%
Enterprise Value	5,480	5,100	4,835	4,593	4,620	4,982
Last Close Price	1300.00	1212.00	1234.09	1200.55	962.97	755.01
PE Ratio	9.34	8.70	11.81	8.20	6.07	-
PS Ratio	0.51	0.47	0.54	0.50	0.44	0.44
PB Ratio	0.50	0.47	0.51	0.56	0.49	0.44
P/TBV Ratio	0.50	0.47	0.51	0.56	0.49	0.44
P/FCF Ratio	66.37	61.87	-	6.62	3.29	6.08
P/OCF Ratio	6.18	5.76	21.54	5.37	2.77	3.27
EV/Sales Ratio	0.44	0.41	0.42	0.36	0.38	0.50
EV/EBITDA Ratio	3.97	3.83	4.55	3.14	3.05	4.67
EV/EBIT Ratio	7.40	7.39	10.16	4.95	5.05	18.05
EV/FCF Ratio	57.68	53.69	-	4.83	2.88	6.94
Debt / Equity Ratio	0.20	0.20	0.21	0.22	0.23	0.25
Debt / EBITDA Ratio	1.86	1.86	2.36	1.72	1.64	2.34
Debt / FCF Ratio	26.13	26.13	-	2.65	1.55	3.48
Asset Turnover	0.71	0.71	0.68	0.76	0.77	0.64
Inventory Turnover	4.66	4.66	4.50	4.62	3.95	3.03
Quick Ratio	1.68	1.68	1.71	1.55	1.41	1.17
Current Ratio	2.23	2.23	2.21	2.01	1.86	1.77
Return on Equity (ROE)	5.48%	5.48%	4.51%	6.98%	8.39%	-0.62%
Return on Assets (ROA)	2.48%	2.48%	1.75%	3.48%	3.63%	1.11%
Return on Capital (ROIC)	2.91%	2.91%	2.10%	4.29%	4.44%	1.36%
Return on Capital Employed (ROCE)	5.30%	5.30%	3.80%	8.00%	8.30%	2.70%
Earnings Yield	10.72%	11.50%	8.47%	12.19%	16.48%	-1.42%
FCF Yield	1.51%	1.62%	-13.33%	15.12%	30.36%	16.46%
Dividend Yield	3.85%	4.13%	4.05%	5.00%	5.71%	2.65%
Payout Ratio	35.50%	35.50%	50.66%	40.81%	24.83%	-
Buyback Yield / Dilution	-0.12%	-0.12%	-0.21%	-0.17%	-0.33%	1.47%
Total Shareholder Return	3.73%	4.00%	3.85%	4.83%	5.38%	4.12%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.